2025-05-07 10:33:19
Mentice has officially launched its treatment planning solution, Ankyras, in Brazil after receiving regulatory clearance from ANVISA, Brazil's National Health Surveillance Agency. According to the company, this marks a significant advancement of intracranial aneurysm care in Latin America, enabling physicians to leverage virtual rehearsal and patient-specific simulation to improve clinical outcomes.
Read the full article at biostock.se:
https://www.biostock.se/2025/05/mentice-launches-ankyras-in-brazil/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se